PBF Energy Shares Soar 1.14% on 30% Crack Rise, UBS Upgrade

Generated by AI AgentAinvest Movers Radar
Wednesday, Jul 9, 2025 6:14 pm ET1min read
PBF--

PBF Energy (PBF) shares surged 1.14% today, marking the sixth consecutive day of gains, with a cumulative increase of 19.10% over the past six days. The stock price reached its highest level since February 2025, with an intraday gain of 2.23%.

PBF Energy's recent stock price movements have been influenced by several key factors. The company experienced a significant rise in benchmark cracks by approximately 30% quarter-over-quarter, indicating potential improvement in refining results. This increase in benchmark cracks suggests that PBFPBF-- Energy's refining operations may be becoming more profitable, which could attract investors and drive up the stock price.


Additionally, brokerage ratings and price targets have played a role in shaping investor sentiment towards PBF EnergyPBF--. UBS GroupUBS-- upgraded the company's rating from "neutral" to "buy" and raised the target price from $20.00 to $26.00. This upgrade reflects a more optimistic outlook on the company's future performance and could encourage investors to buy more shares. However, Citi analyst Vikram Bagri lowered their price target for PBF Energy to $29.00 from $32.00, which may have tempered some of the enthusiasm surrounding the stock.


Technical indicators also provide insight into PBF Energy's stock price movements. The company's shares crossed above their 200-day moving average of $25.17, reaching as high as $25.25 per share. This technical milestone suggests that the stock may be entering a period of sustained growth, as it has broken through a key resistance level. Investors often view such technical indicators as a sign of bullish momentum, which could further drive up the stock price.


Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet